Featured Research

from universities, journals, and other organizations

Dual-capture CTC chip efficiently captures breast cancer cells

Date:
September 29, 2010
Source:
American Association for Cancer Research
Summary:
Researchers have identified a novel, dual-platform technology, the On-Q-ity Circulating Cancer Capture and Characterization Chip, which they believe is more efficient than the commonly used single-platform device in identifying circulating tumor cells, or CTCs, in breast cancer.

Researchers have identified a novel, dual-platform technology, the On-Q-ity Circulating Cancer Capture and Characterization Chip (C5), which they believe is more efficient than the commonly used single-platform device in identifying circulating tumor cells (CTCs) in breast cancer.

Related Articles


Analyzing CTCs in blood can identify cancer cells and cancer cell mutations to provide physicians with methods for improved cancer diagnosis, prognosis and treatment.

In order to efficiently capture CTCs, two capture mechanisms were used to trap CTCs by antibody affinity and size. Gary Palmer, M.D., chief medical officer of On-Q-ity, Inc., Waltham, Mass., and colleagues assessed whether capturing CTCs by using both technologies at the same time was more beneficial and captured a greater number of CTCs than either technology alone.

These laboratory results were presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development, held here.

"It made sense that using both capture methods would be more efficient than either alone. Some CTCs are smaller and often avoid size capture," Palmer said. "Other CTCs have less antigen expression and can also avoid antibody affinity capture. Our dual capture platform provides a better system to ensure that fewer CTCs will be lost."

Using a human breast cancer cell model, the researchers found the On-Q-ity C5 captured a greater number of CTCs; 65 percent of the cells were captured compared to 45 percent of captured cells with the size-based method and 16 percent with antibody affinity.

"Capturing a greater number of CTCs using both mechanisms will hopefully provide better information to help health care providers offer an easier, faster and more accurate diagnosis, treatment prediction and prognosis to their patients," Palmer said.

On-Q-ity researchers are currently conducting additional studies to confirm the usefulness of capturing these CTCs in the clinic, and are learning how to make the processing more sensitive and easier to use. They are also evaluating this platform's use in late-stage breast cancer and colon, prostate and lung cancers.


Story Source:

The above story is based on materials provided by American Association for Cancer Research. Note: Materials may be edited for content and length.


Cite This Page:

American Association for Cancer Research. "Dual-capture CTC chip efficiently captures breast cancer cells." ScienceDaily. ScienceDaily, 29 September 2010. <www.sciencedaily.com/releases/2010/09/100929163413.htm>.
American Association for Cancer Research. (2010, September 29). Dual-capture CTC chip efficiently captures breast cancer cells. ScienceDaily. Retrieved March 30, 2015 from www.sciencedaily.com/releases/2010/09/100929163413.htm
American Association for Cancer Research. "Dual-capture CTC chip efficiently captures breast cancer cells." ScienceDaily. www.sciencedaily.com/releases/2010/09/100929163413.htm (accessed March 30, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, March 30, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com
WH Plan to Fight Antibiotic-Resistant Germs

WH Plan to Fight Antibiotic-Resistant Germs

AP (Mar. 27, 2015) The White House on Friday announced a five-year plan to fight the threat posed by antibiotic-resistant bacteria amid fears that once-treatable germs could become deadly. (March 27) Video provided by AP
Powered by NewsLook.com
House Ready to Pass Medicare Doc Bill

House Ready to Pass Medicare Doc Bill

AP (Mar. 26, 2015) In rare bipartisan harmony, congressional leaders pushed a $214 billion bill permanently blocking physician Medicare cuts toward House passage Thursday, moving lawmakers closer to resolving a problem that has plagued them for years. (March 26) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins